# Kura Oncology, Inc.: Form DEF 14A, filed Apr 10, 2026

- Company: [Kura Oncology, Inc.](/companies/kura.md) (CIK 1422143)
- Form: DEF 14A
- Filed: 2026-04-10
- Accepted by EDGAR: Apr 10, 2026, 16:25 ET
- Period: 2026-06-04
- Accession: 0001193125-26-151335
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422143/000119312526151335/kura-20260410.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422143/000119312526151335/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422143/000119312526151335/kura-20260410.htm

Filed Apr 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-151335. Last ingested by Listed: Nov 11, 2026, 03:30 ET. No prices; not investment advice.
